birth control
-
Introducing MedCity FemFwd, a New Podcast on Women’s Health
MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women’s health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.
-
FDA Nod Makes Perrigo’s Opill the First Oral Contraceptive to Switch to OTC Use
FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
KFF: 77% of Women Are In Favor of Over-the-counter Birth Control Pills
The main factor behind why women want over-the-counter birth control pills is convenience, the survey found. Of those who are unlikely to use over-the-counter birth control pills — or are unsure if they would —most said it’s because they don’t currently use birth control pills or don’t plan to in the future.
-
House report finds PBMs and insurers aren’t covering birth control like ACA requires
The investigation also found that companies denied exceptions requests on average four or more times out of ten, raising barriers to accessing birth control, according to a news release on Tuesday.
-
Is sexism a factor in decision to stop trial of male birth control?
Some ethicists and advocates say it represents a double standard, citing evidence that female contraception also may be related to depression and other side effects. They argue men are being protected from the same unpleasant consequences that women are forced to accept.
-
Cases continue against Bayer’s Essure birth control device, based on a ruling from a federal judge
Bayer previously asked that the lawsuit be dismissed – but John Padova, U.S. District Judge in Philadelphia, has ruled that claims made by two particular women signify legitimate misleading advertising, essentially failing to provide information about certain risks.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Do health policy wonks love their IUDs? Twitter investigates
The subject of IUDs might be controversial to some, but those in the healthcare field are having an open conversation.
-
Supreme Court: Only small, privately held companies can avoid ACA birth control rule
UPDATE: The Supreme Court’s latest ruling about part of the Affordable Care Act is not […]